Hiroki Nakatani Named GHIT Fund’s New Board Chair

The GHIT Fund has named Dr. Hiroki Nakatani, a fomer WHO assistant director-general, its new board chair.

AsianScientist (Jun. 20, 2018) – The Global Health Innovative Technology Fund (GHIT) has announced its appointment of Dr. Hiroki Nakatani, former World Health Organization (WHO) assistant director-general, to the fund’s board of directors and named him its board chair. Nakatani succeeds founding GHIT Board Chair Dr. Kiyoshi Kurokawa, who played an instrumental role in the fund’s growth and achievements in its first five years of operation.

Nakatani served as WHO assistant director-general from 2007 to 2015, where he led the largest technical cluster overseeing HIV/AIDS, tuberculosis, malaria and neglected tropical diseases. During his tenure, the morbidity and mortality of these diseases showed trends of decline, with some tropical diseases moving toward suppression and even eradication in the case of dracunculiasis (guinea worm disease).

“Dr. Nakatani is a pioneer in global health and neglected tropical diseases, with an impeccable science and policy implementation track record. His unparalleled leadership in Japan and internationally in linking health innovation to effective policy and delivery will be critical as GHIT continues to evolve and as its first products hit the market,” said Dr. BT Slingsby, CEO and executive director of the GHIT Fund.

“Dr. Nakatani joins the board at a very exciting time as we’ve also just launched our second five-year phase. And we are grateful to Dr. Kurokawa for his invaluable contributions,” he added.

Prior to joining WHO, Nakatani enjoyed a long career in Japan’s Ministry of Health, Labor and Welfare, where he acquired extensive technical experience in public health, including immunization, health promotion, health emergencies and health workforce development. His senior-level responsibilities in the ministry included a focus on administration, management and organizational as well as legislative development.

As board chair, Nakatani will lead the operations and affairs of GHIT’s board of directors, facilitate good governance, and lead board efforts to realize GHIT’s mission and set future strategic direction.

“I am honored to join the board of this transformational public-private partnership fund for global health R&D. GHIT is a catalytic force in Japan and across the globe, and it is overseen by highly talented, international and experienced governors. It is also humbling to succeed Kiyoshi Kurokawa, who led the GHIT Fund to success so deftly,” said Nakatani.

Nakatani is also currently a specially appointed professor at the Keio University Global Research Institute, in addition to being a specially appointed professor in public health at Osaka University, an advisor for Japan’s Ministry of Health, Labor and Welfare, a director at the National Center for Global Health and Medicine, and a WHO executive board member.


Source: GHIT Fund. Photo Credit: Keio University.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist